Renin-Angiotensin System Blockers and Renal Functional Reserve. Is There a Limit of Renoprotection?

Authors

DOI:

https://doi.org/10.22141/2307-1257.0.4.14.2015.74891

Abstract

Renin-angiotensin system (RAS) blockers (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, direct renin inhibitor) have a renoprotective effect in the presence of preserved glomerular filtration rate in patients with chronic kidney disease. Exhausted renal functional reserve is associated with the loss of renoprotective properties of RAS blockers. There is a need to replace RAS blockers with moxonidine when estimated glomerular filtration rate is less than 30–15 ml/min.

Downloads

Download data is not yet available.

References

National Kidney Foundation. KDOQI Clinical Practice Guideline for Diabetes і CKD: 2012 update // Am. J. Kidney Dis. — 2012. — 60(5). — 850-886.

http://www.health-medix.com/articles/misteztvo/2009-03-24/ 7-14.pdf

Национальные рекомендации. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардионефропротекции. — М.: Российское кардиологическое общество (РКО), Научное общество нефрологов России (НОНР), Национальное общество по изучению атеросклероза (НОА), 2013. — 55 с. // http://www.studfiles.ru/preview/3493621/page:2/

Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (еgfr 45 ml/min) // Statements. (NDT V30, NS2, May 2015)

http://jasn.asnjournals.org/content/11/8/1469/F1.large.jpg

Littlewood K.J., Greiner W., Baum D., Zoellner Y. Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: A cost-effectiveness analysis // BMC Nephrol. — 2007. — 8. — 9.

Домбровский Я.А. Моксонидин в терапии хронической болезни почек, ассоциированной с артериальной гипертензией // Почки. — 2014. — № 2(8). — С. 59-62.

Iseki K., Arima H., Kohagura K., Komiya I., Ueda S. et al. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized control trial // Nephr. Dial. Transpl. — 2013. — V. 28, № 6. — P. 1579-1589.

Downloads

Published

2022-01-19

How to Cite

Ivanov, D. (2022). Renin-Angiotensin System Blockers and Renal Functional Reserve. Is There a Limit of Renoprotection?. KIDNEYS, (4.14), 12–15. https://doi.org/10.22141/2307-1257.0.4.14.2015.74891

Issue

No. 4.14 (2015)

Section

Guest Articles

License

Copyright (c) 2015 D.D. Ivanov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.